Theratechnologies (TH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 11-2019 | 11-2018 | 11-2017 | 11-2016 | 11-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 7,495 | 4,148 | 1,548 | 1,569 | 1,434 |
| Income taxes - deferred | 0 | -1,252 | 0 | 0 | 7 |
| Accounts receivable | 831 | -3,406 | -2,583 | -1,564 | -1,245 |
| Other Working Capital | -3,662 | -37 | 8,465 | -2,333 | 856 |
| Other Operating Activity | -8,055 | 213 | -5,522 | 4,331 | 4,247 |
| Operating Cash Flow | $-3,391 | $-334 | $1,908 | $2,003 | $5,299 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,215 | -23 | -33 | -23 | 51 |
| Purchase Of Investment | -213 | -16,962 | -41,253 | -37,730 | N/A |
| Sale Of Investment | 2,506 | 25,578 | 25,194 | 29,561 | 1,844 |
| Purchase Sale Intangibles | -2,407 | -16 | -41 | -1,167 | 0 |
| Other Investing Activity | 1,199 | -19,267 | 0 | 0 | 0 |
| Investing Cash Flow | $-130 | $-10,691 | $-16,133 | $-9,359 | $1,895 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 56,726 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 0 | 12,822 | 0 | 7,558 |
| Other Financing Activity | -6,807 | -9,837 | 927 | -3,614 | -4,174 |
| Financing Cash Flow | $-6,807 | $46,889 | $13,749 | $-3,614 | $3,384 |
| Exchange Rate Effect | -8 | 1,855 | 1,020 | 333 | 382 |
| Beginning Cash Position | 38,997 | 1,326 | 823 | 11,425 | 519 |
| End Cash Position | 28,661 | 39,045 | 1,368 | 788 | 11,480 |
| Net Cash Flow | $-10,328 | $35,864 | $-476 | $-10,970 | $10,579 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,391 | -334 | 1,908 | 2,003 | 5,299 |
| Capital Expenditure | -3,622 | -39 | -74 | -1,190 | N/A |
| Free Cash Flow | -7,013 | -374 | 1,834 | 813 | 5,299 |